A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : cART / combination antiretroviral therapy

[Related PubMed/MEDLINE]
Total Number of Papers: 2355
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   cART  (>> Co-occurring Abbreviation)
Long Form:   combination antiretroviral therapy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2021 Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. CNS, HAND, HIV-1, ROS
2  2020 A pivotal role for Interferon-alpha receptor-1 in neuronal injury induced by HIV-1. CNS, HAND, IFNAR, IFNAR1KO, tg
3  2020 Absence of peripapillary retinal nerve-fiber-layer thinning in combined antiretroviral therapy-treated, well-sustained aviremic persons living with HIV. CSVD, GCL, HUCs, MRI, PLHIVs, pRNFL, SD-OCT
4  2020 Adeno-Associated Viral Vector Mediated Expression of Broadly- Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target. AAV, bNAbs
5  2020 Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study. GBTM
6  2020 Advances in Developing CAR T-Cell Therapy for HIV Cure. AIDS, CAR-T
7  2020 An Integrated Spatial Dynamics-Pharmacokinetic Model Explaining Poor Penetration of Anti-retroviral Drugs in Lymph Nodes. LNs, PK/PD
8  2020 An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy. pVL
9  2020 Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy. ART, Hb, PI, PIs, SGA, WLHIV
10  2020 Anti-HIV Activity of Standard Combined Antiretroviral Therapy in Primary Cells Is Intensified by CCR5-Targeting Drugs. ---
11  2020 Anti-HIV-1 Antibodies: An Update. bNAbs
12  2020 Assessing the impact of food insecurity on HIV medication adherence in the context of an integrated care programme for people living with HIV in Vancouver, Canada. aOR, PLHIV
13  2020 Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety. HIV, LMV, LPV, MRM, PIs, RTV, TDM, ZDV
14  2020 Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection. CIMT, CVD, HIV-1, IL, USGD
15  2020 B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation. vp17s
16  2020 Blood mitochondrial DNA levels remain elevated from birth to early life in children HIV-exposed uninfected exposed to combination antiretroviral therapy in utero. CHEU, CHUU, mtDNA
17  2020 Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study. aOR, BMD, DEXA, FN, LS, PLHIV, TDF, TH
18  2020 Breastfeeding by Women Living With Human Immunodeficiency Virus in a Resource-Rich Setting: A Case Series of Maternal and Infant Management and Outcomes. HIV
19  2020 Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities. bNAbs, HIV-1
20  2020 CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy. ---
21  2020 CD4/CD8 Ratio Recovery of Children and Adolescents Living With HIV With Virological Suppression: A Prospective Cohort Study. HIV, PYFU
22  2020 Cervical, anal and oral human papillomavirus (HPV) infection in young women: A case control study between women with perinatally HIV infection and women with non-perinatally HIV infection. HPV, HR-HPV
23  2020 Challenges to achieving and maintaining viral suppression among children living with HIV. aHR, aOR, CI
24  2020 Changes in functional connectivity in people with HIV switching antiretroviral therapy. DAN, INSTI, NNRTI, PWH, SSRT
25  2020 Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities. AIDS
26  2020 Clinical Correlates of Human Immunodeficiency Virus-1 (HIV-1) DNA and Inducible HIV-1 RNA Reservoirs in Peripheral Blood in Children With Perinatally Acquired HIV-1 Infection With Sustained Virologic Suppression for at Least 5 Years. HIV-1, SVS
27  2020 Clinical Features and CD4+ T Cells Count in AIDS Patients with CMV Retinitis: Correlation with Mortality. AIDS, CMV, CMVR
28  2020 Clinical manifestations and risk factors for oral immune reconstitution inflammatory syndrome in Mexico. IRIS, IRIS-OLs, PLWH
29  2020 Clinico-Immunological Status and Neurocognitive Function of Perinatally Acquired HIV-Positive Children on cART: A Cross-Sectional Correlational Study in South Africa. PHIV
30  2020 Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. ---
31  2020 Composition and Orientation of the Core Region of Novel HIV-1 Entry Inhibitors Influences Metabolic Stability. ---
32  2020 Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? ANI, HAND
33  2020 Correlates of health-related quality of life among adults receiving combination antiretroviral therapy in coastal Kenya. FAHI, HRQoL, PLWHA
34  2020 COVID-19 and AIDS: Outcomes from the coexistence of two global pandemics and the importance of chronic antiretroviral therapy. AIDS, COVID-19, HIV, SARS-CoV-2
35  2020 CRF01_AE and CRF01_AE cluster 4 are associated with poor immune recovery in Chinese patients under cART. IR
36  2020 Dasatinib protects humanized mice from acute HIV-1 infection. CML, GALT, TKIs
37  2020 Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral Therapy. aHR, HBV
38  2020 Decreased time to viral suppression after implementation of targeted testing and immediate initiation of treatment of acute HIV infection among men who have sex with men in Amsterdam. AHI, MSM, SOC
39  2020 Defective HIV-1 proviruses produce viral proteins. ORFs, PBMCs
40  2020 Deficits in bone strength, density and microarchitecture in women living with HIV: A cross-sectional HR-pQCT study. WLWH
41  2020 Detectability of HIV Residual Viremia despite Therapy Is Highly Associated with Treatment with a Protease Inhibitor-Based Combination Antiretroviral Therapy. GEE, PI, RV, VL
42  2020 Development and optimization of a simian immunodeficiency virus (SIV) droplet digital PCR (ddPCR) assay. ddPCR, MGB, NHP, SIV
43  2020 Differences in location of cerebral white matter hyperintensities in children and adults living with a treated HIV infection: A retrospective cohort comparison. FLAIR, WMH
44  2020 Disruption of brain network organization in patients with human immunodeficiency virus (HIV) infection. HAND, HIV
45  2020 Disseminated Mycobacterium avium on HIV/AIDS: Historical and Current Literature Review. DMAC, PLHA
46  2020 Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings. DSPN, HIV, PLWH, RLSs
47  2020 Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles? ---
48  2020 Does switching from multiple to single-tablet regimen containing the same antiretroviral drugs improve adherence? A group-based trajectory modeling analysis. STR
49  2020 Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy. CHARTER, CNS, CSF, DRMs, HAND, SGA
50  2020 Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa. bPI, GRT, HIV-1C, INSTIs, NNRTI, NRTI, PI, PIs, PLHIV-1, RAMs, RTIs
51  2020 Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections. ddPCR
52  2020 Dyslipidaemia after switch to tenofovir alafenamide (TAF)-based cART regimens in a cohort of HIV-positive patients: what clinical relevance? aOR, CI, CV, ESC/EAS, LDL, TAF
53  2020 Early and Successful Combination Antiretroviral Therapy Normalizes Survival Time in Patients Coinfected With Human Immunodeficiency Virus and Human T-cell Lymphotrophic Virus Type 1. HIV, HTLV-1, pVL
54  2020 Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children. ADCC, bNAbs, HIV, NAb
55  2020 Effect of combination antiretroviral therapy on the clinical manifestations, radiological characteristics, and disease severity of HIV-associated Talaromyces marneffei infection. CT, HIV
56  2020 Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients. ADR, DTG
57  2020 Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study. HAD, HAD
58  2020 Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T cell Responses to PD-L1 Blockade. ICB, mAbs
59  2020 Efficacy of Three Antiretroviral Regimens Initiated during Pregnancy: Clinical Experience in Rio de Janeiro. VL
60  2020 Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients. CI, HIV-1, MOR, SHCS
61  2020 Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria. ADR, CIs, ORs, PLWH
62  2020 Extracellular Vesicle Activation of Latent HIV-1 Is Driven by EV-Associated c-Src and Cellular SRC-1 via the PI3K/AKT/mTOR Pathway. EV
63  2020 Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance. EVs
64  2020 Factors associated with immunosenescence during early adulthood in HIV-infected patients after durable efficient combination antiretroviral therapy. KRECs, TL, TRECs
65  2020 Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal. HIV
66  2020 gamma-Non-symmetrically-dimasked TriPPPro-prodrugs as potential antivirals against HIV. NRTI, NTPs
67  2020 Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4+ T Cell Subsets during Long-Term Combination Antiretroviral Therapy. ---
68  2020 Health care issues affecting transgender people living with HIV: an opportunity for improvement. IQR, Tg, VL
69  2020 Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV. HBV, HCV, NHL, OR
70  2020 HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE. POC, SOC
71  2020 Higher iron stores and the HFE 187C>G variant delay onset of peripheral neuropathy during combination antiretroviral therapy. ACTG, hs-CRP, PWH, sTfR
72  2020 HIV and risk of dementia in older veterans. aHR, PLWH
73  2020 HIV Care Continuum and Meeting 90-90-90 Targets: Cascade of Care Analyses of a U.S. Military Cohort. CI, DHHS, DoD, VS
74  2020 HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History. HAND
75  2020 HIV infects astrocytes in vivo and egresses from the brain to the periphery. BBB, NSG, PBMCs
76  2020 HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy. ---
77  2020 HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design. ---
78  2020 HIV-1 Maturation: Lessons Learned from Inhibitors. ALLINIs, CA, MIs, PR, SP1
79  2020 HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages. CVD, HANA, HAND
80  2020 HIV-1 Tat-Induced Astrocytic Extracellular Vesicle miR-7 Impairs Synaptic Architecture. CNS, EV, HIV-1, miR-7, NLGN2, PDGF-CC, Tat
81  2020 HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review. HAM, HAND
82  2020 HIV-Infected Mothers Who Decide to Breastfeed Their Infants Under Close Supervision in Belgium: About Two Cases. HIV, WHO
83  2020 Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection. ddPCR, HIV
84  2020 Hypervitaminosis A is associated with immunological non-response in HIV-1-infected adults: a case-control study. INR, VL
85  2020 Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors That Potently Reactivate Latent HIV. LRAs
86  2020 Identification, management and outcomes of combination antiretroviral treatment failure in adolescents with perinatal HIV infection in Asia. LTFU, PHIVA
87  2020 Immune reconstitution inflammatory syndrome in the central nervous system: Limitations for diagnosis in resource limited settings. CNS IRIS, CSF, RLS, TB
88  2020 Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ Tcell death by pyroptosis. HIV, RTE
89  2020 Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals. EBV, HIV, HL, LPD, NHL
90  2020 Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study. CLHIV, LLV, pVL, PYFU, VF
91  2020 Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-Tuberculosis Co-Therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations. BMI, TB
92  2020 Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting. CAP, IPD, IRR, PLWH, PYFU
93  2020 Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom. CI
94  2020 Innovations for prevention and care of oral candidiasis in HIV-infected individuals: Are they available?-A workshop report. IRIS, OC
95  2020 Integrating Comprehensive Geriatric Assessment Into HIV Care Systems in Indonesia: A Synthesis of Recent Evidence. CGA, HIV
96  2020 Liberation from Dialysis Dependence in a Patient with HIV-Associated Nephropathy (HIVAN) after Combined Antiretroviral Therapy (cART). ESRD, HIVAN, HIVAN
97  2020 Long-Term Impact of Calcium and Vitamin D Supplementation on Bone Density in HIV+ Patients with Documented Deficiencies. BMD, DEXA
98  2020 Management of HIV-infected patients in the intensive care unit. ---
99  2020 Management of Intraocular Infections in HIV. AIDS, HIV
100  2020 Maximizing viral detection with SIV droplet digital PCR (ddPCR) assays. ddPCR, SIV